Home > Offer to Sell > Pharmaceuticals and Biochemicals > Antineoplastics agents > Lapatinib base

Lapatinib base

Inquiry
  Post Date: Dec 07,2013
  Expiry Date: Jun 05,2014
  Detailed Description: Cas No. :231277-92-2 Lapatinib base

  CAS Registry Number:

231277-92-2

  Synonyms: ;4-Quinazolinamine, N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-;N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine;N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-Quinazolinamine;N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-amine;Lapatinib base;
  Molecular Formula: C29H26ClFN4O4S
  Molecular Weight: 581.0575
  Molecular Structure: 231277-92-2 Lapatinib

  Company: Guangzhou Wanqian Pharmaceutical Technology Co., LTD     [ China ]        
  Contact: Taylor Wong
  Tel: 86-20-29078958
  Fax:
  Email: sales@eastbangpharma.com
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.